Lipoprotein apheresis results in plaque stabilization and prevention of cardiovascular events: comments on the prospective Pro(a)LiFe study

Elevated lipoprotein(a) (Lp(a)) has emerged as an important independent cardiovascular risk factor, and causal association has been accepted with adverse outcome in atherosclerotic disease. Lipoprotein apheresis (LA) can lower low-density lipoprotein (LDL)-cholesterol and Lp(a) by 60–70 % and is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Klingel, Reinhard, Heibges, Andreas, Fassbender, Cordula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361723/
https://www.ncbi.nlm.nih.gov/pubmed/25644612
http://dx.doi.org/10.1007/s11789-015-0068-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361723/
https://www.ncbi.nlm.nih.gov/pubmed/25644612
http://dx.doi.org/10.1007/s11789-015-0068-y

Ejemplares similares